SRC and hepatocellular carcinoma: Regarding clinical outcomes, elevated SRC expression—defined as median cut-off value of 0.50 a.u. in HCC nodules—was noticed in patients with poorer prognosis after 24 months, both in terms of recurrence and overall survival, although the differences did not reach statistical significance (Figure 1C).